SRPK2 and colorectal cancer: The same authors showed that SRPK2 promotes pancreatic cancer progression by downregulating Numb and p53, and this negative regulation also occurred following 5-fluorouracil or cisplatin treatment in colorectal cancer cells [(37, 59).